About the National Center for Toxicological Research
Jefferson Laboratories are OPEN for normal operations (Feb. 27, 2015).
The National Center for Toxicological Research (NCTR), is the only FDA Center located outside the Washington D.C. metropolitan area. The one-million square foot research campus in Jefferson, Arkansas plays a critical role in the missions of FDA and the Department of Health and Human Services to promote and protect public health.
Regulatory science researchers, academia, and other regulatory science research organizations and groups from around the world investigate, learn, and train at the Federal facility. NCTR, FDA's internationally recognized research center, plays a critical role in FDA’s mission. The unique scientific expertise of NCTR is critical in supporting FDA product centers and their regulatory roles.
About NCTR Research
About NCTR's Bioinformatics Tools
- Decision Forest
- Estrogenic Activity Database (EADB)
- Endocrine Disruptor Knowledge Base (EDKB)
- Gene Ontology for Functional Analysis (GOFFA)
- Liver Toxicity Knowledge Base (LTKB)
- MicroArray Quality Control (MAQC)
- NCTR Liver Cancer Database (NCTRltcb)
About NCTR's Organization
- Contact NCTR
- NCTR Key Officials
- Organization Chart
- Searchable HHS Employee Phone Directory (Searchable database by agency)
More About NCTR
- Jobs and Training Opportunities at NCTR
- Subscribe to NCTR Mailing Lists
- FDA-Track: Quarterly Briefing Summaries of Program Performance
- NCTR Advisory Committees
- NCTR FOIA Electronic Reading Room
NCTR in the Press ...
BPA and Babies: New Research From FDA Focuses On What Happens In Womb
- FDA, state of Arkansas sign agreement to advance regulatory science
Feds Reject Petition To Ban BPA In Food Landmark Birthday for FDA Research Center[ARCHIVED] Leading Environmental Group Scientist Praises FDA's Ground-Breaking Research On BPA: A Tipping Point In The Controversy Little Rock firm develops rapid test for E. coli bacteria Today's THV takes you inside the National Center for Toxicological Research Unraveling the Microbiome US Lead in Nanotechnology Depends on Growth of FDA and Government Initiiatives